NFE2L2 and Hyperglycemia: The activation of NRF2 and subsequent upregulation of antioxidant proteins represent a promising novel therapeutic target for the prevention or management of diabetic complications, particularly where hyperglycemia-induced oxidative stress is closely associated with elevated free radical production.